|
Bristol-Myers Squibb Co. said Saturday that its experimental drug for chronic myeloid leukemia led to remission in a significant number of patients who had failed to respond to the leading treatment. The company presented the results of three trials of the drug, dasatinib, at different stages of the disease -- a slow-progressing bone marrow cancer -- at the annual meeting of the American Society of Hematology in Atlanta. New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
